4p16.3 Microduplication Syndrome
Oncology·MeSH: Myoclonus, Cerebellar Ataxia, and Deafness
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target 4p16.3 Microduplication Syndrome?
There are 1 clinical trial targeting 4p16.3 Microduplication Syndrome tracked by BioSniper.
What is the prevalence of 4p16.3 Microduplication Syndrome?
The estimated prevalence of 4p16.3 Microduplication Syndrome is approximately 0.1 per 100,000 population.
Deep-dive into 4p16.3 Microduplication Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis